Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.63
Delayed Data
As of Feb 24
 +0.0099 / +1.60%
Today’s Change
0.33
Today|||52-Week Range
1.15
+16.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$30.5M

Company Description

Oragenics, Inc. is a biopharmaceutical company. The company is focused on developing novel antibiotics against infectious disease and treatments for oral mucositis . It also develops, markets and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Contact Information

Oragenics, Inc.
4902 Eisenhower boulevard
Tampa Florida 33634
P:(813) 286-7900
Investor Relations:

Employees

Shareholders

Other institutional7.14%
Individual stakeholders49.91%
Mutual fund holders1.01%

Top Executives

Alan F. JoslynPresident, Chief Executive Officer & Director
Michael O'Keefe SullivanChief Financial Officer, Secretary & Treasurer
Martin HandfieldSenior Vice President-Discovery Research